Home

Valiant Laboratories Ltd EPS

Image

Valiant Laboratories Ltd

NSE: VALIANTLAB

EPS

₹ -0.51

Last updated on: Jul 04, 2025

Key Highlights

  • The Earning per Share of Valiant Laboratories Ltd is ₹ -0.51 as of 04 Jul 25 .
  • The earning per share of Valiant Laboratories Ltd changed from ₹ 1.31 to ₹ 0.16 over 8 quarters. This represents a CAGR of -65.05% .

Historical Earning per Share of Valiant Laboratories Ltd

No data available

* All values are in

Company Fundamentals for Valiant Laboratories Ltd

Market Cap

503 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

2.2

Day’s High

118.95

Day’s Low

115.45

DTE

0.5

ROE

-0.9

52 Week High

157.55

52 Week Low

75.86

ROCE

-0.4

Market Price of Valiant Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Valiant Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Jul 2025115.95
03 Jul 2025115
02 Jul 2025114.65
01 Jul 2025111.8
30 Jun 2025113.05
27 Jun 2025115.35
26 Jun 2025113.1
25 Jun 2025116.05
24 Jun 2025114.25
23 Jun 2025111.75

SWOT Analysis Of Valiant Laboratories Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Valiant Laboratories Ltd

Asset Value vs Market Value of Valiant Laboratories Ltd

Market Value

504

Asset Value

Value addition

1.7 X

189

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Valiant Laboratories Ltd503.8
Sun Pharmaceutical Industries Ltd402285
Divis Laboratories Ltd183268
Cipla Ltd122247
Torrent Pharmaceuticals Ltd113983
Dr Reddys Laboratories Ltd108921

Historical Market Cap of Valiant Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Valiant Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Valiant Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Valiant Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Valiant Laboratories Ltd News Hub

Valiant Laboratories reports consolidated net loss of Rs 0.51 crore in the June 2024 quarter

Net loss of Valiant Laboratories reported to Rs 0.51 crore in the quarter ended June 2024 as against

Read more

13 Aug 24

Valiant Laboratories to conduct board meeting

Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2024.

Read more

09 Aug 24

Valiant Laboratories to hold board meeting

Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 7 February 2025

Read more

01 Feb 25

Valiant Laboratories to conduct board meeting

Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 12 November 202

Read more

08 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Valiant Laboratories Ltd

What is the EPS of Valiant Laboratories Ltd stock?

The Earnings Per Share (EPS) of Valiant Laboratories Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Valiant Laboratories Ltd EPS calculated?

The EPS of Valiant Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Valiant Laboratories Ltd report its EPS?

Valiant Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Valiant Laboratories Ltd EPS?

Factors that influence the EPS of Valiant Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Valiant Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Valiant Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions